Pasireotide-d7 (TFA)

• UNSPSC Description:

  Pasireotide-d7 (TFA) is the deuterium labeled Pasireotide TFA[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Field of Research:

  Others

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(C(F)(F)F)=O.O=C1N2[C@@](C(N[C@](C3=CC=CC=C3)([H])C(N[C@@H](C(N[C@H](C(N[C@H](C(N[C@H]1CC4=CC=CC=C4)=O)CC5=CC=C(C=C5)OC([2H])([2H])C6=C([2H])C([2H])=C([2H])C([2H])=C6[2H])=O)CCCCN)=O)CC7=CNC8=CC=CC=C78)=O)=O)([H])C[C@H](C2)OC(NCCN)=O.[3]

• Molecular Weight:

  1396.31

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported